1. Alien, R. E. and Stimmel, G. L. (1977). Neuroleptic dosage, duration and T.D. Dis. Nerv. Syst., 38, 385–387
2. American College of Neuropsychopharmacology — Food and Drug Administration Task Force (1973). Neurologic syndromes associated with anti-psychotic drug use. New Engl. J. Med., 289, 20–23
3. Ayd, F. J., Jr. (1970). Prevention of recurrence (maintenance therapy). Clinical Handbook of Psychopharmacology (Ed. A. DiMascio and R. I. Schader), Science House, New York, pp. 297–310
4. Birket-Smith, E. (1974). Abnormal involuntary movements induced by anticholinergic therapy. Acta neurol. scand., 50, 801–811
5. Bockenheimer, S. and Lucius, G. (1976). Zer Therapie mit Dimethyl Aminoethanol (Deanol) bei Neuroleptikain Duzierten Extrapyramidalen Hyperkinesen. Arch. Psychiat., 222, 69–75